Translated material
Clinical trials of the first vaccine from acne began
The French pharmaceutical company Sanofi has begun the initial stage of clinical testing of the acne vaccine. In case of successful testing, the drug will become the first in the world such a vaccine. It is reported by Live Science.
At the same time, according to the publication, there are no available test data that would confirm that the vaccine is working. The study should be completed by 2027. During this period, Sanofi plans to get about 400 adults aged 18 to 45, suffering from a moderate or severe form of acne on the face. Some of the participants will receive up to three injection of the vaccine, while the control group will be introduced to a placebo without active substances.
I moved to London at 43 years old I was a journalist in Moscow, emigrated twice, and now I am studying for a psychoanalyst for 12 minutes of reading
Live Science notes that the company has not disclosed any details about how exactly the vaccine will act. From open sources it is known that this is an MRNC-vaccine. Once in the body, it encourages the immune system to attack certain proteins.
According to the publication, to ensure that the vaccine has become accessible to patients, it usually leaves about 10 years from the moment the drug begins to develop and approval for wide use. So, even if the first test of safety and the effectiveness of the new vaccine will give positive results, it will be necessary to conduct much more tests before it falls into the medical institutions.
For which they planted the most devoted General Putin and that this can tell us about all the structure of the army and the state of the policy 9 minutes of reading
Live Science writes that Sanofi scientists are not the only ones who are developing an acne vaccine. California scientists work on the same problem, but French researchers probably advanced further than others in their work.
In order not to miss the main materials of the "cold", subscribe to our social networks!
